drugset / Trial / NCT00947323

Simvastatin for Treating Erectile Dysfunction

NCT00947323

Phase 3 Completed 41 enrolled Santa Casa de Porto Alegre
RandomizedSingle-groupDouble-blindTreatment

Summary

This is a randomized clinical trial, double-blind, placebo controlled, to verify if simvastatin can improve erectile dysfunction in men with endothelial dysfunction, without any cardiac disease.It is hypothesized that the simvastatin can improve the endothelial function, improving the nitric oxide liberation in corpora cavernosa of the penis, resulting in improvement of erection.

Timeline

Start
2006-01
Primary completion
2008-07
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 20 mg